Empowerment-based Complementary and Alternative Medicine (ECAM) - Trial NCT06317584
Access comprehensive clinical trial information for NCT06317584 through Pure Global AI's free database. This phase not specified trial is sponsored by Chang Gung University of Science and Technology and is currently Not yet recruiting. The study focuses on Diabetes. Target enrollment is 86 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Chang Gung University of Science and Technology
Timeline & Enrollment
N/A
Apr 01, 2024
Jul 31, 2025
Primary Outcome
Understanding the benefits-risks of complementary therapies (CTs) use scale Alternative Medicine (CAM) use questionnaire,Quality of life questionnaire,Diabetes Empowerment scale
Summary
This phase study will use a randomized trial method to evaluate the performance of the ECAM
 educational app in the promotion of CAM health literacy and communication among patients with
 diabetes.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06317584
Non-Device Trial